GE Healthcare and molecular breast imaging developer Dilon Diagnostics announced the U.S. Food and Drug Administration (FDA) clearance of GE's molecular breast imaging (MBI) localization accessory for breast biopsy.
Dilon is the exclusive distributor of GE's Discovery NM750b molecular breast imaging system in North America. The system is designed to measure and image the distribution of selected single photon emission radioisotopes to aid in lesion evaluation. The MBI localization accessory complements the Discovery NM750b breast imaging system, which is designed to locate, in 3D, breast lesions using information from stereotactic pairs of 2D images.
The Discovery NM750b system and the breast biopsy accessory will be presented at RSNA 2016 in Chicago.
